Literature DB >> 15634962

Synergy tests by E test and checkerboard methods of antimicrobial combinations against Brucella melitensis.

Gani Orhan1, Aysen Bayram, Yasemin Zer, Iclal Balci.   

Abstract

Two different synergy testing methods, the checkerboard and the E test methods, were used to compare the in vitro efficacies of various antimicrobial combinations against 16 Brucella melitensis strains isolated from blood cultures. The rate of agreement of the E test and checkerboard methods was found to be 55%. The most concordant results were found for the streptomycin-doxycycline combination in 12 (75%) tests, in which four strains showed synergistic activity by E test and antagonistic activity by the checkerboard method and in which one strain showed antagonistic activity by both methods. Even though each of these methods uses different conditions and endpoints, the results of both methods frequently agreed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15634962      PMCID: PMC540140          DOI: 10.1128/JCM.43.1.140-143.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  3 in total

1.  Evaluation of antibiotic synergy against Acinetobacter baumannii: a comparison with Etest, time-kill, and checkerboard methods.

Authors:  C R Bonapace; R L White; L V Friedrich; J A Bosso
Journal:  Diagn Microbiol Infect Dis       Date:  2000-09       Impact factor: 2.803

2.  Comparison of three different in vitro methods of detecting synergy: time-kill, checkerboard, and E test.

Authors:  R L White; D S Burgess; M Manduru; J A Bosso
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

3.  Activities of levofloxacin, ofloxacin, and ciprofloxacin, alone and in combination with amikacin, against acinetobacters as determined by checkerboard and time-kill studies.

Authors:  S Bajaksouzian; M A Visalli; M R Jacobs; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

  3 in total
  100 in total

1.  An Automated Miniaturized Method to Perform and Analyze Antimicrobial Drug Synergy Assays.

Authors:  Peter Chase; Imarhia Enogieru; Franck Madoux; Eric Bishop; Jacob Beer; Louis Scampavia; Timothy Spicer
Journal:  Assay Drug Dev Technol       Date:  2015-12-15       Impact factor: 1.738

2.  Treatment of Multidrug-Resistant Vancomycin-Resistant Enterococcus faecium Hardware-Associated Vertebral Osteomyelitis with Oritavancin plus Ampicillin.

Authors:  Samira Dahesh; Brian Wong; Victor Nizet; George Sakoulas; Truc T Tran; Samuel L Aitken
Journal:  Antimicrob Agents Chemother       Date:  2019-06-24       Impact factor: 5.191

3.  A short synthetic peptide, based on LyeTx I from Lycosa erythrognatha venom, shows potential to treat pneumonia caused by carbapenem-resistant Acinetobacter baumannii without detectable resistance.

Authors:  William Gustavo Lima; Júlio César Moreira Brito; Maria Elena de Lima; Amanda Cristina Silva Tardelli Pizarro; Maria Auxiliadora Martins de Mello Vianna; Magna Cristina de Paiva; Débora Cristina Sampaio de Assis; Valbert Nascimento Cardoso; Simone Odília Antunes Fernandes
Journal:  J Antibiot (Tokyo)       Date:  2021-05-10       Impact factor: 2.649

4.  AB569, a nontoxic chemical tandem that kills major human pathogenic bacteria.

Authors:  Cameron T McDaniel; Warunya Panmanee; Geoffrey L Winsor; Erin Gill; Claire Bertelli; Michael J Schurr; Prateek Dongare; Andrew T Paul; Seung-Hyun B Ko; Gee W Lau; Nupur Dasgupta; Amy L Bogue; William E Miller; Joel E Mortensen; David B Haslam; Phillip Dexheimer; Daniel A Muruve; Bruce J Aronow; Malcolm D E Forbes; Marek Danilczuk; Fiona S L Brinkman; Robert E W Hancock; Thomas J Meyer; Daniel J Hassett
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-18       Impact factor: 11.205

5.  Hitting the caspofungin salvage pathway of human-pathogenic fungi with the novel lasso peptide humidimycin (MDN-0010).

Authors:  Vito Valiante; Maria Cândida Monteiro; Jesús Martín; Robert Altwasser; Noureddine El Aouad; Ignacio González; Olaf Kniemeyer; Emilia Mellado; Sara Palomo; Nuria de Pedro; Ignacio Pérez-Victoria; José R Tormo; Francisca Vicente; Fernando Reyes; Olga Genilloud; Axel A Brakhage
Journal:  Antimicrob Agents Chemother       Date:  2015-06-08       Impact factor: 5.191

6.  Chemical Induction of Aminoglycoside Uptake Overcomes Antibiotic Tolerance and Resistance in Staphylococcus aureus.

Authors:  Lauren C Radlinski; Sarah E Rowe; Robert Brzozowski; Alec D Wilkinson; Rennica Huang; Prahathees Eswara; Brian P Conlon
Journal:  Cell Chem Biol       Date:  2019-08-08       Impact factor: 8.116

Review 7.  When does 2 plus 2 equal 5? A review of antimicrobial synergy testing.

Authors:  Christopher D Doern
Journal:  J Clin Microbiol       Date:  2014-06-11       Impact factor: 5.948

8.  Application of Antimicrobial Peptides of the Innate Immune System in Combination With Conventional Antibiotics-A Novel Way to Combat Antibiotic Resistance?

Authors:  Maria S Zharkova; Dmitriy S Orlov; Olga Yu Golubeva; Oleg B Chakchir; Igor E Eliseev; Tatyana M Grinchuk; Olga V Shamova
Journal:  Front Cell Infect Microbiol       Date:  2019-04-30       Impact factor: 5.293

9.  Tobramycin and bicarbonate synergise to kill planktonic Pseudomonas aeruginosa, but antagonise to promote biofilm survival.

Authors:  Karishma S Kaushik; Jake Stolhandske; Orrin Shindell; Hugh D Smyth; Vernita D Gordon
Journal:  NPJ Biofilms Microbiomes       Date:  2016-05-25       Impact factor: 7.290

10.  Synergistic and additive effects of epigallocatechin gallate and digitonin on Plasmodium sporozoite survival and motility.

Authors:  Janina K Hellmann; Sylvia Münter; Michael Wink; Friedrich Frischknecht
Journal:  PLoS One       Date:  2010-01-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.